Full Text View
Tabular View
No Study Results Posted
Related Studies
Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1
This study is ongoing, but not recruiting participants.
Study NCT00657202   Information provided by Massachusetts General Hospital

First Received on March 27, 2008.   Last Updated on March 4, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Neurofibromatosis Type 1
Cutaneous Neurofibromas
Additional conditions recognized in this trial
Neurofibroma
Neurofibromatoses
Neurofibromatosis 1
Osteitis Fibrosa Cystica
More general conditions related to this trial
Bone Diseases
Bone Diseases, Endocrine
Genetic Diseases, Inborn
Heredodegenerative Disorders, Nervous System
Musculoskeletal Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Nerve Tissue
Neoplastic Syndromes, Hereditary
Nerve Sheath Neoplasms
Nervous System Diseases
Nervous System Neoplasms
Neurocutaneous Syndromes
Neurodegenerative Diseases
Neuromuscular Diseases
Peripheral Nervous System Diseases
Peripheral Nervous System Neoplasms
Interventions listed in this trial
Ranibizumab
Sponsors listed in this trial
Massachusetts General Hospital


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services